Eli Lilly Surges with a 45% Revenue Jump to $12.7 Billion in Q1, Fueled by Weight-Loss and Diabetes Drugs

Eli Lilly's first-quarter revenue soared by 45% to $12.73 billion, powered by the sales of Mounjaro and Zepbound. The company also announced a $50 billion expansion to meet growing...